Assuming you are a VC investor in healthcare. Let me know which of these two email templates below interests you the most if any.
Dear David
We have a unique approach to cancer drug discovery that will reduce timelines for cancer treatment developments by enhancing access to critical research and data. Current delays in information impact the timing of drugs which will mean life or death for millions of people each year. Most innovative cancer drugs are facing delays in reaching patients, because regulators are not keeping up with the pace of progress along with the shortage of human resources leading to delays from patent to patients, for current cancer patients a delay of just a few weeks could mean life or death.
We are solving this issue by building a platform where researchers and scientists freely exchange ideas, data, and information related to cancer. This unrestricted access removes barriers and allows specialists from diverse fields to build on each other’s work,
I would like an opportunity to have a call with you and show you how this works
How about this Thursday at 3:30 pm?
Emmanuel.
Vs
Subj: Seek advice
Hello Mr/Mrs X
The current landscape of cancer treatment development is marked by significant delays, jeopardizing the lives of millions of patients. The challenges, ranging from regulatory hurdles to resource shortages, have prompted us to devise a unique approach that accelerates the exchange of crucial research and data among scientists and researchers.
By creating an environment that fosters open collaboration, which no one is doing, we break down barriers and expedite the journey from patent to patients allowing scientists to build on each other’s work. This is especially crucial for cancer patients, where even a brief delay could be a matter of life or death.
Our approach has the potential to make a substantial impact on the timely delivery of groundbreaking cancer treatments.
The purpose of this message is to ask for an opportunity to meet you and show how this works How about this Thursday at 3:30 pm?
Emmanuel
Please let me know what you think of this.
Hi David
We have developed a revolutionary strategy for cancer treatment discovery that cuts the normal speed-to-market of cancer drugs by over 90%. Most novel cancer treatments are experiencing delays in reaching patients. The most promising new therapies have not been effectively fast-tracked due to regulators’ inability to keep up with the rate of research, and this is an industry where a week’s delay can mean life or death for hundreds of thousands of people.
At AccelerateOncology, our objective is to facilitate collaboration between pharmaceutical companies in countries with severe and lengthy treatment adoption processes and those with less and more accommodating constraints, decreasing the process from 10 -13 years to 1-2 years in time of adoption.
This method benefits around 21 million people each year in a global market worth approximately $180 billion.
If you are around for 15 minutes, I would love to show this to you had an exit at X, We can also continue this over email.
Best, Emmanuel